DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Profit & Loss Account Balance History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit & Loss Account Balance | ₹13,400 Cr | ₹11,786 Cr | ₹10,959 Cr | ₹9,989 Cr | ₹7,598 Cr |
What is the latest Profit & Loss Account Balance ratio of DIVIS LABORATORIES ?
Year | Profit & Loss Account Balance |
---|---|
Mar2025 | ₹13,400 Cr |
Mar2024 | ₹11,786 Cr |
Mar2023 | ₹10,959 Cr |
Mar2022 | ₹9,989 Cr |
Mar2021 | ₹7,598 Cr |
How is Profit & Loss Account Balance of DIVIS LABORATORIES Trending?
Years | Profit & Loss Account Balance | % Change | |
---|---|---|---|
Mar2025 | ₹13,400 Cr | 13.69 | |
Mar2024 | ₹11,786 Cr | 7.55 | |
Mar2023 | ₹10,959 Cr | 9.71 | |
Mar2022 | ₹9,989 Cr | 31.47 | |
Mar2021 | ₹7,598 Cr | - |
Compare Profit & Loss Account Balance of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹175,741.1 Cr | -1.7% | 0.5% | 47.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,991.0 Cr | -0.1% | 1.3% | 5% | Stock Analytics | |
CIPLA | ₹120,133.0 Cr | 0.4% | -1.5% | -1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,994.0 Cr | -0.2% | 9% | 13.3% | Stock Analytics | |
MANKIND PHARMA | ₹106,806.0 Cr | -2.5% | 12.1% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,562.0 Cr | 0.5% | -5.7% | -9.1% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -1.7% |
0.5% |
47.2% |
SENSEX | -0.1% |
0.2% |
2.1% |
You may also like the below Video Courses